Figure 2.
Type 1 diabetes risk stratification by islet autoantibody properties: Increase in T1D risk is associated with progression of islet autoantibodies from single to multiple autoantibodies. Characteristics of the initial antibody response can help predict disease progression. (IAA, insulin autoantibodies; GAD65, glutamic acid decarboxylase 65; IA-2, islet-associated autoantibody 2; ZnT8, zinc transporter 8;